---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-046330"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2024-11-15T23:59:59+00:00"
generated_at: "2026-05-29T23:54:17.153027+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics closes $7.5M public offering of 4.44M shares at $1.69/share

## Summary
- Gross proceeds ~$7.5M from 4,437,869 shares at $1.69; closed Nov 15, 2024.
- Net proceeds for working capital, general corporate purposes, and pre-clinical/clinical trials.
- Placement agent Ladenburg Thalmann gets 8% cash fee, 1% mgmt fee, and warrants for 221,893 shares at $2.1125.
- Lock-ups: company 15 days, insiders 90 days; CEO may sell up to 10K shares after 25 days for tax planning.
- Offering under effective S-3 shelf; proceeds expected to extend cash runway for clinical-stage biotech.

## SEC filing metadata
- accession: 0001493152-24-046330
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2024-11-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315224046330/0001493152-24-046330-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315224046330/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-046330
- JSON: https://secwatch.observer/filing/0001493152-24-046330.json
- Plain text: https://secwatch.observer/filing/0001493152-24-046330.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.